期刊文献+

L-精氨酸盐酸盐/磷脂酰胆碱脂质体的制备及其对ATP的分子识别 被引量:4

Preparation of L-Arg.HCl/Phosphatidylcholine Liposome and Molecular Recognition to ATP
在线阅读 下载PDF
导出
摘要 用L 精氨酸盐酸盐和磷脂酰胆碱制备了L 精氨酸盐酸盐 磷脂酰胆碱脂质体受体,研究了受体与腺苷三磷酸(ATP)在脂质体亲脂区通过分子间氢键进行的分子识别。透射电镜表征发现脂质体呈明显的双层膜圆球形,粒径100~200nm;并对氢键识别作用进行了UV Vis光谱研究。 Coliposomes from phosphatidylcholine and arginine hydrochloride have been prepared by rotating-film evaporating technique.We in estigated the mixture of the coliposomes and adenosine-5'-triphosphate disodium salt(ATP)with UV-Vis spectroscopy to detect whether recognition of host-guest can be achieved in lipid spherical bilayer structures.The appearances and diameters of coliposomes were characterized by trasmission electron microphotography(TEM)exhibiting sphere in shape with diameter 100~200nm and bilayer structure.UV-Vis spectroscopy show that,when ATP was added into L-Arg·HCl/PC coloposomes,the absorbity of ATP at 259 nm decreased slowly with time.This result can be ascribed to ATP-guanidium interaction of hydrogen-bonding and demonstrate that it is accessible to achieve the process of molecular recognition in liposome systems.
出处 《化学研究与应用》 CAS CSCD 北大核心 2005年第1期49-51,共3页 Chemical Research and Application
关键词 脂质体 胍基 ATP 分子识别 liposome guanidium ATP molecular recognition
  • 相关文献

参考文献12

  • 1李凤前,胡晋红.肝靶向给药系统研究的新进展[J].中国药学杂志,2002,37(5):321-325. 被引量:12
  • 2Mitchell P. Federation of European Biochemical Societies Lett. 1974,43(2) : 189 - 194.
  • 3Boyer PD. Anna Rev Biochem, 1997,66:717- 749.
  • 4Boyer PD. Membrane Bioenegetics, 1979,2486 - 2491.
  • 5Senior AE, Weber J, Nadanaciva S.J bioenerg Biomembr,2000,32(5) : 523 - 529.
  • 6Nadanaciva S, Weber J, Senior AE. J Biol Chem. 1999,274:7052 - 7058.
  • 7Omote H, Wada Y, Nakamoto RK, Futai M. Biochem(Article) ,2000,39(10) :2778 - 2783.
  • 8Feichtinger K, Heather CZ, Sings L, Goodman M. J Org Chem 1998,63:3804 - 3805.
  • 9Sasaki DY, Kurihara K, Kunitake T. J Am Chem Soc.1991,113:9685 - 9686.
  • 10Itojima Y, Ogawa Y,Tsuno K, Hanada N,et al. Biochem,1992,31:4757 - 4765.

二级参考文献29

  • 1张志荣.肝靶向米托蒽醌白蛋白微球的研究[J].药学学报,1997,32(1):72-78. 被引量:22
  • 2Shimizu K, Maitani Y, Takayama K, et al. Evaluation of dipalmitoylphosphatidylcholine liposomes containing a soybean-derived sterylglucoside mixture for liver targeting[J].J Drug Target,1996,4(4):245.
  • 3Okuno K,Nakamura K,Tanaka A,et al.Hepatic immunopotentiation by galactose-entrapped liposomal IL-2 compound in the treatment of liver metastases[J].Surg Today,1998,28(1):64.
  • 4Kumar V,Banker GS.Targeted-Oriented Drug Delivery Systems[A].In:Banker GS,Rhodes CT eds.Modern Pharmaceutics.3ed.vol.72[M].New York: Marcel Dekker,1996:611-680.
  • 5Korba BA, Xie H, Wright KN,et al. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo[J].Hepatology,1996,23(5):958.
  • 6Song SC, Soo-Sohn Y.Synthesis and hydrolytic properties of polyphosphazene/(diamine)platinum/saccharide conjugates[J]. J Controlled Release,1998,55(2-3):161.
  • 7Hashida M, Akamatsu K, Nishikawa M, et al. Design of polymeric prodrugs of PGE1 for cell-specific hepatic targeting[J].Pharmazie,2000,55(3):202.
  • 8Fiume L,Bassi B,Busi C,et al. Drug targeting in antiviral chemotherapy[J].Biochem Pharmcol,1986,35(6):967.
  • 9Di-stefano G, Colonna FP, Bongini A, et al. Ribavirin conjugated with lactosaminated poly-L-lysine: selective delivery to the liver and increased antiviral activity in mice with viral hepatisis[J].Bichem Pharmacol,1997,54(3):357.
  • 10Fiume L, Di-stefano G, Busi C, et al. Hepatotropic conjugate of adenine arabinoside monophosphated withlactosaminated poly-L-lysine. Synthesis of the carrier and pharmacological properties of the conjugate[J].J Hepatol,1997,26(2):253.

共引文献11

同被引文献59

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部